Modus Advisors’s Bionano Genomics BNGO Stock Holding History

Modus Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2	Closed	-$35	–	128
2024 Q4	$35	Buy	+2	New	+$34	﹤0.01%	317
2021 Q3	–	Sell	-5	Closed	-$21K	–	119
2021 Q2	$21K	Buy	+5	New	+$19.7K	0.01%	192

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Modus Advisors's BNGO Position: Q1 2025 in Review

Modus Advisors sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 2 shares — an estimated $35 sold.

Modus Advisors first reported a position in BNGO in Q2 2021 and held it in 2 quarters. The position peaked at $21K in Q2 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

Modus Advisors reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
Modus Advisors sold 2 Bionano Genomics shares in Q1 2025, an estimated $35.
Modus Advisors first reported a position in Bionano Genomics in Q2 2021 and held it in 2 quarters.
Modus Advisors's Bionano Genomics position peaked at $21K in Q2 2021.
30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Modus Advisors's 13F filing for Q1 2025, filed 1 Apr 2025.